Based on the laboratory results (LH ≈5 IU/L, FSH ≈6 IU/L, testosterone ≈250 ng/dL in a male or estradiol ≈30 pg/mL in a female), what Tanner stage of puberty does the patient correspond to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Interpretation for Tanner Staging

Based on the provided hormone levels (LH ≈5 IU/L, FSH ≈6 IU/L, testosterone ≈250 ng/dL in males or estradiol ≈30 pg/mL in females), these values correspond to mid-puberty, specifically Tanner stage 3-4.

Interpretation by Sex

For Males (Testosterone ≈250 ng/dL)

The testosterone level of approximately 250 ng/dL (≈8.7 nmol/L) falls within Tanner stage 3-4 based on established reference data 1. According to guideline-referenced normative values:

  • Tanner G3: Nocturnal testosterone ≈3.76 nmol/L (108 ng/dL), Diurnal ≈0.62 nmol/L
  • Tanner G4: Nocturnal testosterone ≈9.83 nmol/L (283 ng/dL), Diurnal ≈1.99 nmol/L
  • Tanner G5: Nocturnal testosterone ≈13.2 nmol/L (380 ng/dL), Diurnal ≈7.80 nmol/L 1

Your patient's testosterone of ~250 ng/dL places them between G3 and G4, most consistent with mid-to-late Tanner stage 3 or early stage 4.

The gonadotropin levels (LH ≈5 IU/L, FSH ≈6 IU/L) support active pubertal progression. Research demonstrates that LH rises precipitously in early puberty and plateaus during mid-to-late puberty 2. FSH increases more gradually throughout puberty 2. These gonadotropin levels are consistent with established puberty rather than early pubertal activation.

For Females (Estradiol ≈30 pg/mL)

The estradiol level of approximately 30 pg/mL (≈110 pmol/L) corresponds to Tanner stage 2-3 based on guideline data 1:

  • Tanner B2: Nocturnal estradiol ≈38.5 pmol/L (10.5 pg/mL), Diurnal ≈56.3 pmol/L (15.3 pg/mL)
  • Tanner B3: Nocturnal estradiol ≈81.7 pmol/L (22.2 pg/mL), Diurnal ≈107.3 pmol/L (29.2 pg/mL)
  • Tanner B4: Nocturnal estradiol ≈162.9 pmol/L (44.3 pg/mL), Diurnal ≈132.3 pmol/L (36.0 pg/mL) 1

Your patient's estradiol of ~30 pg/mL places them at late Tanner stage 2 or early stage 3.

The gonadotropin levels (LH ≈5 IU/L, FSH ≈6 IU/L) are elevated above prepubertal values and consistent with active puberty. Research shows that mean overnight LH rises log-linearly from 0.2 IU/L prepubertally to 3.0 IU/L in late puberty, while FSH rises from 1.0 IU/L to approximately 2.8 IU/L by Tanner III-V 3. Your patient's values exceed these mid-pubertal benchmarks, suggesting more advanced pubertal status than the estradiol alone would indicate.

Clinical Context and Caveats

Important Considerations:

Timing of Sample Collection Matters: Hormone levels vary significantly between nocturnal and diurnal measurements, particularly for LH and testosterone in males 1, 2. The values provided likely represent random daytime samples, which may underestimate nocturnal peaks, especially in early-to-mid puberty.

Physical Examination is Essential: Laboratory values should always be correlated with physical Tanner staging 1:

  • Males: Testicular volume is the most reliable physical indicator. Tanner G3 corresponds to testicular volume >6-12 mL with penile lengthening 1
  • Females: Breast development stage (B2 = breast bud, B3 = further enlargement without areolar separation) 1

Wide Variability Within Stages: Research demonstrates that hormone levels can vary 100-fold within early Tanner stages for LH, and 16-fold for FSH 3. This means individual values may not perfectly align with physical staging.

Sex-Specific Patterns: Girls typically have higher FSH levels than boys at comparable pubertal stages 3, 4. The FSH of 6 IU/L is more consistent with female mid-puberty than male mid-puberty based on sex-specific reference ranges.

Diagnostic Algorithm:

  1. Correlate with physical examination - Measure testicular volume in males (orchidometer) or assess breast development in females
  2. Consider timing - If possible, obtain early morning samples for more accurate assessment
  3. Assess growth velocity - Mid-puberty typically shows peak height velocity
  4. Evaluate bone age - Should be advancing in parallel with pubertal progression
  5. If discordance exists between labs and physical exam, consider repeat testing or dynamic testing (GnRH stimulation test) 5, 6

Related Questions

At what age do most adolescent males reach Tanner stage 5 (the final stage of genital development)?
In a male patient with FSH 49 U/L, LH 33 U/L, estradiol 50 pg/mL, progesterone <0.5 ng/mL, total testosterone 53 ng/dL, free testosterone 3.7 pg/mL, and SHBG 141 nmol/L, what is the likely diagnosis and appropriate treatment plan?
When should serum luteinizing hormone (LH) and follicle‑stimulating hormone (FSH) be measured in men, and how do the results help differentiate primary versus secondary hypogonadism and guide further evaluation?
For a 66-year-old man with elevated follicle‑stimulating hormone (FSH) 27.2 IU/L, normal luteinizing hormone (LH) 7.2 IU/L, total testosterone 549 ng/dL, free testosterone 111 pg/mL, and sex hormone‑binding globulin (SHBG) 37 nmol/L, what is the recommended management regarding scrotal ultrasound, urology referral, and treatment?
What is the most likely diagnosis in a 15-year-old male with delayed puberty (Tanner stage I genitalia, sparse axillary and pubic hair), reduced height percentile, anosmia, and a history of bilateral orchidopexy for cryptorchidism and cleft palate repair?
What are the current guidelines for the management of acute testicular torsion?
Should a patient who started buspirone (Buspar) one week ago, taking half a tablet twice daily, discontinue the medication because she develops headache, itchy and runny nose after the second dose that resolves by morning?
Should imaging be obtained for a patient with a muscle‑exposing laceration that has become infected?
How should the laboratory results be interpreted to assess the stage of puberty in a 15-year-9-month-old adolescent?
Is sumatriptan safe to use in a patient with non‑ST‑elevation myocardial infarction (NSTEMI)?
What is the expected duration of healing for an osteoporotic lumbar compression fracture in an elderly patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.